about
Nonstructural 5A protein of hepatitis C virus interacts with pyruvate carboxylase and modulates viral propagationType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightMetabolic alterations and hepatitis C: From bench to bedsideSteatosis and hepatitis CPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVHuman immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohortRecurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus InfectionOxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis CRisk factors for fatty liver in the Multicenter AIDS Cohort Study.Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionModulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.Hepatitis C virus infection and nonalcoholic steatohepatitisOngoing liver inflammation in patients with chronic hepatitis C and sustained virological responseChronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.Chronic hepatitis C virus infection: genotyping and its clinical role.Hyperferritinemia is a risk factor for steatosis in chronic liver disease.Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.Hepatitis C and diabetes: the inevitable coincidence?Cellular and molecular biology of HCV infection and hepatitis.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.Metabolic alterations and chronic hepatitis C: treatment strategies.The predictive value of steatosis in hepatitis C virus infection.Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?An insight into the molecular characteristics of hepatitis C virus for clinicians.Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined ExperimentallyDeleterious impact of maternal hepatitis-C viral infection on maternal and fetal outcome: a 5-year prospective study.Hepatitis virus C infection, adipokines and hepatic steato-fibrosis.The impact of host metabolic factors on treatment outcome in chronic hepatitis C.Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.
P2860
Q24309143-3C463FDF-2711-4B44-BD4E-DB5853CA96B0Q26752583-18316CE2-2C1B-4B14-8B96-632A5C4AFC81Q26773261-29AEF7B3-4EE5-4A20-B5EA-9E5EFACE982DQ26798101-7FEF7897-45F9-4716-A680-E4FB6927C94BQ26861095-1D598E23-5CB1-4406-BD0E-E8BA57D3D8F8Q28079826-6AC3C572-7FC3-464E-BE22-6EA381AFCB6FQ31149395-8F0C5383-BE11-46D9-B76E-0341909EB0B8Q33335491-7D323E3E-F979-489E-B533-B73CA78729EBQ33871776-5990D045-B63D-45E1-A9BF-39F875EF4A7EQ33904328-EEBEA0DD-DFBA-4CBE-A99F-C9053D2F5750Q33993946-AAF136A4-B079-4D45-85EE-1F33EB51BF65Q34049896-72096496-405D-4BDA-BC1C-3B69A426DEE8Q34263370-501A8274-D6C5-476F-B7A0-3D677E889156Q34401965-A055DC41-A5A0-4398-A174-133DC255F669Q34698082-2004C552-1561-4F8A-B077-1D15DCD4395CQ35956085-309068D3-5A3F-46BE-B4D0-7C9FE0E34948Q36111496-128FA415-3786-4D64-AB3D-ED3473F0E7DCQ36179898-2D5C6CD8-ED7A-4787-A0EB-3CFED53C6339Q36280109-5B095EE8-F89B-45A1-B0E4-AF9A36E2E1ADQ36612862-3A06FDA5-CF87-49CA-9065-DA19AA66401DQ36895749-64CC1574-2D67-4AE2-8874-4FD21A2FDC56Q37182959-6A0D6A01-BEC0-4EA5-8904-C6BB907BAB14Q37217299-7B516680-3B3B-4A0D-9286-51EB8436532AQ37432092-3ED63552-757F-4193-9051-23BDC24F17AEQ37514366-39E25F24-58BB-48CA-BB7F-9A6B1A8FD3CBQ37685491-529B1BAC-A8E6-4ADE-A1FF-98AB524CB194Q37788976-01DE9253-A71B-4C6E-A5D4-52F7B70CB82DQ37924816-96ECA7C9-DB62-4777-8398-C6637353DACBQ38085061-FA01AB28-6D5E-4E68-BC97-6BFDDBD56E7BQ38170504-07376CE4-0C1C-4DA2-A6AA-FF39ED711484Q38825949-E87A86E5-6046-4D5E-96F3-46BC8DA91D7FQ39340978-11EDA11A-2DA4-4A5E-8006-2318A191942CQ40484068-8A242E0A-7067-44AE-A0AD-957C2166C46EQ40543016-7AA570B4-F369-45A7-ABE3-9AB2F7481F96Q41929016-EAB0F22B-E380-4C4B-B167-0B4FA014D2F4Q41972145-9F3577C8-0357-4628-BAF9-7C8CB312D65DQ42152130-552914D8-A8C9-4D46-AC75-94DF84747B09Q42981153-E18A5EEB-4993-42A2-8457-B4F636D6A686Q42994549-CD58211C-4DFC-4D92-9554-6729A87578A3Q43035090-949C252C-BB03-47E0-A55F-FAD6A01FBDD8
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hepatitis C and steatosis: a reappraisal.
@ast
Hepatitis C and steatosis: a reappraisal.
@en
type
label
Hepatitis C and steatosis: a reappraisal.
@ast
Hepatitis C and steatosis: a reappraisal.
@en
prefLabel
Hepatitis C and steatosis: a reappraisal.
@ast
Hepatitis C and steatosis: a reappraisal.
@en
P2093
P2860
P1476
Hepatitis C and steatosis: a reappraisal.
@en
P2093
P2860
P356
10.1111/J.1365-2893.2005.00669.X
P577
2006-02-01T00:00:00Z